BACILLARY ANGIOMATOSIS

BACILLARY ANGIOMATOSIS was reported 136 times

BACILLARY ANGIOMATOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Selective T Cell Costimulation Blocker [EPC] 8 0.0017
1 Antimetabolite Immunosuppressant [EPC] 25 0.0012
2 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 11 0.0005
3 Calcineurin Inhibitor Immunosuppressant [EPC] 31 0.0002
4 Echinocandin Antifungal [EPC] 1 0.0001
5 Tetracycline-class Drug [EPC] 8 0.0001
6 Purine Antimetabolite [EPC] 10 0.0001
7 Corticosteroid [EPC] 101 0.0001
8 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 6 0.0001
9 Vitamin D Analog [EPC] 1 0.0001
10 Macrolide Antimicrobial [EPC] 2 0.0000
11 Alkylating Drug [EPC] 8 0.0000
12 Glycopeptide Antibacterial [EPC] 2 0.0000
13 Polyene Antifungal [EPC] 1 0.0000
14 Thiazide Diuretic [EPC] 5 0.0000
15 Protease Inhibitor [EPC] 1 0.0000
16 CD20-directed Cytolytic Antibody [EPC] 7 0.0000
17 Erythropoiesis-stimulating Agent [EPC] 1 0.0000
18 Cytochrome P450 3A Inhibitor [EPC] 1 0.0000
19 Kinase Inhibitor [EPC] 9 0.0000
20 Leukocyte Growth Factor [EPC] 2 0.0000
21 Topoisomerase Inhibitor [EPC] 1 0.0000
22 Nucleoside Analog Antiviral [EPC] 1 0.0000
23 Aromatase Inhibitor [EPC] 1 0.0000
24 Fluoroquinolone Antibacterial [EPC] 1 0.0000
25 Loop Diuretic [EPC] 3 0.0000
26 Aldosterone Antagonist [EPC] 1 0.0000
27 RANK Ligand Inhibitor [EPC] 1 0.0000
28 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
29 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
30 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
31 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
32 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
33 Benzodiazepine [EPC] 1 0.0000